HYDROXYALKYL STARCH FOR THE TREATMENT OF CANCERS BY REDUCTION OF TUMOR GROWTH RATES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160082036A1
SERIAL NO

14958249

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to hydroxyalkyl starch or a pharmaceutical preparation thereof for the treatment of cancer, tumor or tumor associated diseases, especially by effectively reducing tumor growth rate and inhibiting tumor growth and wherein the hydroxyalkyl starch has a mean molecular weight (MW) above 20 and below 1300 kDa and a molar substitution (MS) in the range of from 0.1 to 1.5, wherein the alkylation may be an ethylation, propylation or butylation or mixes thereof; and wherein the alkyl may be further substituted.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FRESENIUS KABI DEUTSCHLAND GMBHELSE-KRONER-STRASSE 1 BAD HOMBURG 61352

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baasner, Silke Schoneck, DE 26 138
Westphal, Martin Bad Homburg, DE 13 155

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation